Dotixa

Dasatinib

Category:

Chemical

Chemical

Oral

Oral

Dosage form :

Tablets

Doses :

70/100 mg

Short Description:

Dotixa contains the active substance dasatinib. Dotixa is used to treat Philadelphia chromosome positive (pH+) Chronic Lymphoblastic Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) in adults, adolescents, and children at least 1 year of age who are not benefiting from prior therapies.

Product Introduction

What Dotixa is and what it is used for

Dotixa contains the active substance Dasatinib.

Dotixa is used to treat Philadelphia chromosome positive (Ph+) Chronic Myeloid Leukemia (CML) in adults, adolescents and children at least 1 year of age who are not benefiting from prior therapies.

Dotixa is also used to treat Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents and children at least 1 year of age. In people with ALL, white cells called lymphocytes multiply too quickly and live too long. Dotixa inhibits the growth of these leukemic cells.

If you have any questions about how Dotixa works or why this medicine has been

Prescribed for you, ask your doctor.

Sunitinib

Chemical

Chemical

Oral

Oral

Palbociclib

Chemical

Chemical

Oral

Oral

Zoledronic Acid

Chemical

Chemical

Injectable

Injectable